Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Fiorica

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Oncology and Therapy|July 24, 2020
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a FlukeLorenzo Belluomini, Francesco Fiorica, Antonio Frassoldati
International Journal of Molecular Sciences|March 6, 2021
Resveratrol as Chemosensitizer Agent: State of Art and Future PerspectivesVeronica Cocetta, Vincenzo Quagliariello, Francesco Fiorica, et al.
Journal of Clinical Medicine|June 13, 2025
Oral Bisphosphonates for Colorectal Cancer Prevention: A Meta-Analytic Reappraisal Beyond Bone HealthEnrico Altiero Giusto, Rossella Donghia, Carlotta Giorgi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 5, 2021
Dose-escalation strategy in refractory metastatic colorectal cancer: A change in terms of cost-effectivenessJacopo Giuliani, Francesco Fiorica, Giovanni Ponturo, et al.
Journal of Clinical Medicine|September 28, 2024
"Defendit Numerus": A Pooled Analysis of 6145 Locally Advanced Rectal Cancer Treated with Preoperative ChemoradiotherapyJacopo Giuliani, Marta MandarĂ , Marco Muraro, et al.
Cancers|April 30, 2021
Mitochondrial Control of Genomic Instability in CancerMassimo Bonora, Sonia Missiroli, Mariasole Perrone, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 28, 2020
The role of fentanyl in the treatment of breakthrough cancer pain: Different biotechnologies, different results and different drug costsJacopo Giuliani, Francesco Fiorica, Alfredo Sacchetto, et al.
Journal of Clinical Medicine|May 4, 2026
Metastatic Colorectal Cancer Beyond Third-Line Treatment: Systematic Review and Meta-Analysis of Later-Line TherapiesJacopo Giuliani, Emilia Durante, Daniela Mangiola, et al.
Cancers|January 11, 2025
Metabolic-Modulating Effects of Radiation: Undetectable Yet Deadly-A Review on RadiotherapyFrancesco Fiorica, Umberto Tebano, Giuseppe Napoli, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and MetanalysisFrancesco Fiorica, Consuelo Buttigliero, Daniela Grigolato, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Oncology and Therapy|July 24, 2020
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a FlukeLorenzo Belluomini, Francesco Fiorica, Antonio Frassoldati
International Journal of Molecular Sciences|March 6, 2021
Resveratrol as Chemosensitizer Agent: State of Art and Future PerspectivesVeronica Cocetta, Vincenzo Quagliariello, Francesco Fiorica, et al.
Journal of Clinical Medicine|June 13, 2025
Oral Bisphosphonates for Colorectal Cancer Prevention: A Meta-Analytic Reappraisal Beyond Bone HealthEnrico Altiero Giusto, Rossella Donghia, Carlotta Giorgi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 5, 2021
Dose-escalation strategy in refractory metastatic colorectal cancer: A change in terms of cost-effectivenessJacopo Giuliani, Francesco Fiorica, Giovanni Ponturo, et al.
Journal of Clinical Medicine|September 28, 2024
"Defendit Numerus": A Pooled Analysis of 6145 Locally Advanced Rectal Cancer Treated with Preoperative ChemoradiotherapyJacopo Giuliani, Marta MandarĂ , Marco Muraro, et al.
Cancers|April 30, 2021
Mitochondrial Control of Genomic Instability in CancerMassimo Bonora, Sonia Missiroli, Mariasole Perrone, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 28, 2020
The role of fentanyl in the treatment of breakthrough cancer pain: Different biotechnologies, different results and different drug costsJacopo Giuliani, Francesco Fiorica, Alfredo Sacchetto, et al.
Journal of Clinical Medicine|May 4, 2026
Metastatic Colorectal Cancer Beyond Third-Line Treatment: Systematic Review and Meta-Analysis of Later-Line TherapiesJacopo Giuliani, Emilia Durante, Daniela Mangiola, et al.
Cancers|January 11, 2025
Metabolic-Modulating Effects of Radiation: Undetectable Yet Deadly-A Review on RadiotherapyFrancesco Fiorica, Umberto Tebano, Giuseppe Napoli, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and MetanalysisFrancesco Fiorica, Consuelo Buttigliero, Daniela Grigolato, et al.
Pageof 8